Atrovent Inhalation, oral/nebulization and Moxetumomab Pasudotox-tdfk
Determining the interaction of Atrovent Inhalation, oral/nebulization and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Atrovent
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atrovent Inhalation, oral/nebulization-Moxetumomab pasudotox-tdfk Intravenous
- Atrovent Inhalation, oral/nebulization-Moxifloxacin
- Atrovent Inhalation, oral/nebulization-Moxifloxacin (Systemic)
- Atrovent Inhalation, oral/nebulization-Moxifloxacin Hydrochloride
- Atrovent Inhalation, oral/nebulization-Moxifloxacin Injection
- Atrovent Inhalation, oral/nebulization-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Atrovent Nasal
- Moxetumomab Pasudotox-tdfk-Atrovent Nasal Spray
- Moxetumomab Pasudotox-tdfk-Atrovent Nasal Spray eent
- Moxetumomab Pasudotox-tdfk-ATryn
- Moxetumomab Pasudotox-tdfk-Attapulgite Liquid and Suspension
- Moxetumomab Pasudotox-tdfk-Attapulgite Tablet